11:15am today!! Sat Mar 4th. Brace yourself!































LDL reduction 20-25% in study. Remind us again... statins 40%, PCSK9 50-70%. So more adverse events in BA arm with gout leading the way. No difference in death in BA arm and placebo. 14k patients and this was the best they could do?? Really?
 






All the bravado talk about runways,upticks,traction all come down to 1115am. Will see how this gets spinned.
Landmark CLEAR Outcomes Study Demonstrates NEXLETOL® (bempedoic acid) Tablet is the Only LDL-C Lowering Therapy Since Statins to Reduce Hard Ischemic Events in a Broad Population of Both Primary Prevention and Secondary Prevention Patients
 






The stock has been throttled today due to investors not convinced the weak data will drive sales. You needed to be prepared for this with your Plan b. Nothing changes that the data wasn't robust enough.